Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Change in Account Payables (2021 - 2023)

Werewolf Therapeutics (HOWL) has disclosed Change in Account Payables for 3 consecutive years, with -$104000.0 as the latest value for Q3 2023.

  • Quarterly Change in Account Payables rose 88.57% to -$104000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $136000.0 through Sep 2023, up 207.09% year-over-year, with the annual reading at -$883000.0 for FY2022, 187.69% down from the prior year.
  • Change in Account Payables for Q3 2023 was -$104000.0 at Werewolf Therapeutics, up from -$616000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $1.1 million in Q2 2021, with the low at -$1.5 million in Q3 2021.
  • Average Change in Account Payables over 3 years is $33181.8, with a median of -$104000.0 recorded in 2023.
  • The sharpest move saw Change in Account Payables crashed 193.09% in 2022, then skyrocketed 242.58% in 2023.
  • Over 3 years, Change in Account Payables stood at $651000.0 in 2021, then tumbled by 116.13% to -$105000.0 in 2022, then grew by 0.95% to -$104000.0 in 2023.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$104000.0, -$616000.0, and $961000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.